The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity
Shizan Xu,Peiqin Niu,Kan Chen,Yujing Xia,Qiang Yu,Ning Liu,Jingjing Li,Sainan Li,Liwei Wu,Jiao Feng,Wenwen Wang,Xiya Lu,Tong Liu,Fan Wang,Weiqi Dai,Xiaoming Fan,Wenhui Mo,Ling Xu,Chuanyong Guo
DOI: https://doi.org/10.1038/s41598-017-15521-3
IF: 4.6
2017-11-09
Scientific Reports
Abstract:Hepatic ischemia reperfusion (IR) injury contributes to the morbidity and mortality associated with liver surgery. This study investigated the protective function and mechanism of propylene glycol alginate sodium sulfate (PSS), a sulfated polysaccharide, in a mouse hepatic IR injury model. PSS (25 or 50 mg/kg) or saline were injected intraperitoneally to male Balb/c mice 1 h before 45 min of 70% warm hepatic ischemia and 2, 8, and 24 h of reperfusion. Serum and liver tissue samples were collected for evaluation of hepatocellular damage, liver histology, and assay of inflammatory cytokines, apoptosis- and autophagy-related proteins, and proteins in the mitogen-activated protein kinase (MAPKs). Histological injury and release of transaminases, and inflammatory cytokine production were significantly reduced by PSS pretreatment. The expression of apoptosis- and autophagy-related proteins, and the activation of MAPK signal, including jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and P38 were all affected by PSS treatment compared with IR model controls. PSS protected the liver from IR injury by suppressing the MAPK signaling and down-regulating inflammation, apoptosis, and autophagy.
multidisciplinary sciences